Electromed, Inc. Common Stock
Key Metrics
- Previous Close
- $39.45
- 52-Week Range
- $19.93 – $47.40
- Market Cap
- $333.60M
- P/E (TTM)
- 34.44
- EPS (TTM)
- 1.17
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 6.79
- PEG Ratio
- 0.35
- Return on Equity
- 21.70%
- Return on Assets
- 14.86%
- Gross Margin
- 78.44%
- Operating Margin
- 20.28%
- Profit Margin
- 14.08%
- Current Ratio
- 4.91
- Debt/Equity
- 0.00
- Total Debt
- $81.00K
- Free Cash Flow
- $8.32M
- Revenue Growth
- 18.40%
- Earnings Growth
- 66.70%
- Enterprise Value
- $316.70M
Market Snapshot
About
Electromed, Inc. (ELMD) is a medical device company headquartered in New Prague, Minnesota, focused on airway clearance therapy systems for patients with chronic pulmonary conditions.
The company develops and manufactures the SmartVest line of airway clearance devices. Its core technology is High Frequency Chest Wall Oscillation, or HFCWO therapy. This therapy uses an air pulse generator connected to an inflatable vest garment to deliver oscillating pressure to a patient's chest wall, helping to clear mucus from the lungs. Its primary systems include the SmartVest SQL System and the SmartVest Clearway System, along with a wireless SmartVest Connect platform that enables data sharing between patients and physicians. Electromed serves patients with compromised pulmonary functions such as bronchiectasis and cystic fibrosis, as well as individuals with neuromuscular diseases like cerebral palsy and muscular dystrophy.
Electromed markets its products to physicians and other healthcare providers, and also engages in direct sales to patients. For acute care settings like hospitals, the company offers single-patient use versions of its products, including the SmartVest Wrap. The company sells its devices primarily in the United States, with some international distribution. Electromed was founded and incorporated in 1992.